Decoy Therapeutics (SLRX) Live Share Price, Invest From India

Decoy Therapeutics Stock Performance

as on January 8, 2026 at 7:59 am IST

Day's Low
Day's High
$0.69
Day's Price Range
$0.89
$0.83
16.87%
Downside
7.23%
Upside
52 Week's Low
52 Week's High
$0.51
52-Week Price Range
$3.31
$0.83
37.98%
Downside
298.75%
Upside

Decoy Therapeutics share price movements today

Previous Close: $0.65
Open: $0.73
Volume: 5.8M
Day's Low - High: $0.69 - $0.89
52 Week Low - High: $0.51 - $3.31

Decoy Therapeutics Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Decoy Therapeutics Stock Fundamentals & Key Indicators

Check Decoy Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Decoy Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Decoy Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Decoy Therapeutics	Hold	$-	NA	NA	0.00%	0.00%
Insmed	StrongBuy	$22.9B	229.05%	-37.04	84.26%	0.00%
Alnylam Pharma	StrongBuy	$22.1B	-1.58%	8.10	77.28%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Regeneron	Buy	$99.4B	52.18%	20.73	85.77%	0.38%

Analyst Recommendation on Decoy Therapeutics Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Decoy Therapeutics. Average target price of $26

Decoy Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Decoy Therapeutics.

What analysts predicted

96.81%UPSIDE

Target Price

$26

Current Price

$0.83

Analyzed by

6 Analysts

Target

$26.00

Decoy Therapeutics target price $26, a slight upside of 96.81% compared to current price of $0.83. According to 6 analysts rating.

Decoy Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-2	0	-1	-1	0	-1	-1	0	0
Net Profit Margin	0.00%	0.00%	-4928.44%	0.00%	0.00%	0.00%	-33075.76%	0.00%	0.00%	0.00%

Decoy Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	0	3	5	1	-	-	-
Gross Profit	0	0	0	3	5	1	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-39	-34	-21	-6	-7	-12	-31	-12	-5
Net Profit Margin	-3906.33%	-2700.71%	-2615.99%	-200.18%	-140.49%	-693.84%	0.00%	0.00%	0.00%

Global Institutional Holdings in Decoy Therapeutics

Check out the Institutions with significant holdings in Decoy Therapeutics.

Funds	Holdings
TWO SIGMA SECURITIES, LLC	0.00%
HRT FINANCIAL LLC	0.41%
UBS Group AG	0.24%
Cubist Systematic Strategies, LLC	0.22%
Geode Capital Management, LLC	0.20%

See all

Insights on Decoy Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, SLRX stock has moved up by 28.8%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 889.3% return, outperforming this stock by 989.0%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 167.8% return, outperforming this stock by 264.4%

About Decoy Therapeutics

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. It is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold.

Organisation

Decoy Therapeutics

FAQs

What is Decoy Therapeutics share price today?

Decoy Therapeutics share price today is $0.83 as on January 8, 2026 at 2:29 am IST. Decoy Therapeutics share today touched a day high of $0.89 and a low of $0.69.

What is the 52 week high and 52 week low for Decoy Therapeutics share?

Decoy Therapeutics share touched a 52 week high of $3.31 on November 6, 2025 and a 52 week low of $0.51 on January 5, 2026. Decoy Therapeutics stock price today i.e. January 8, 2026 at 2:29 am IST is trending at $0.83,which is 74.92% down from its 52 week high and 61.23% up from its 52 week low.

How to invest in Decoy Therapeutics Stock (SLRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Decoy Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Decoy Therapeutics Stock (SLRX) from India?

Indian investors can start investing in Decoy Therapeutics (SLRX) shares with as little as ₹93.91000366210938 or $1 (as of November 7, 2026 at 1:20 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Decoy Therapeutics stock (as per the Rupee-Dollar exchange rate as on November 7, 2026 at 1:20 am IST). Based on Decoy Therapeutics share’s latest price of $0.83 as on January 8, 2026 at 2:29 am IST, you will get 12.0482 shares of Decoy Therapeutics. Learn more about fractional shares .